Use of a specific antagonist of 5HT.sub.2 receptors for preparaing medicines useful for treating sleep-disordered breathing
AssigneeSanofi-Synthelabo
InventorFran.cedilla.oise Cattelin
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of a specific 5HT2 receptor antagonist for the preparation of medicines useful in the treatment of the sleep apnea syndrome.
Claims4
A method for the treatment of sleep apnea syndrome which comprises administering to a patient in need of such treatment an effective amount of 1-(2-fluorophenyl)-3-(4-hydroxyphenyl)-prop-2-en-1-one-O-(2-dimethylami noethyl)-oxime or of one of its pharmaceutically acceptable salts.
A method for the treatment of sleep obstructive apnea-hypoapnea syndrome which comprises administering to a patient in need of such treatment an effective amount of 1-(2-fluorophenyl)-3-(4-hydroxyphenyl)-prop-2-en-1-one-O-(2-dimethylaminoe thyl)-oxime or of one of its pharmaceutically acceptable salts.
Dependencies are inferred from the claim text.